LAVAL, Quebec (AP) _ Bausch Health Companies Inc. (BHC) on Wednesday reported a loss of $1.52 billion in its fourth quarter.

On a per-share basis, the Laval, Quebec-based company said it had a loss of $4.30. Earnings, adjusted for non-recurring costs and amortization costs, were $1.15 per share.

The results matched Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was also for earnings of $1.15 per share.

The drugmaker posted revenue of $2.22 billion in the period, also meeting Street forecasts.

For the year, the company reported that its loss narrowed to $1.79 billion, or $5.08 per share. Revenue was reported as $8.6 billion.

Bausch expects full-year revenue in the range of $8.65 billion to $8.85 billion.

Bausch shares have declined 6% since the beginning of the year. The stock has increased 10% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BHC at https://www.zacks.com/ap/BHC

Automated Insights, source Associated Press News